Hematological Malignancies
Showing 51 - 75 of 3,813
Pediatric Cancer, Solid Tumor Pediatric, Hematological Malignancies Trial in Worldwide (Durvalumab / Tremelimumab Combination
Active, not recruiting
- Pediatric Cancer
- +2 more
- Durvalumab / Tremelimumab Combination Therapy
-
Baltimore, Maryland
- +18 more
Nov 3, 2022
Lymphoma, Multiple Myeloma Trial in China (Etoposide, Cytarabine, PEG-rhG-CSF)
Recruiting
- Lymphoma
- Multiple Myeloma
- Etoposide
- +2 more
-
Hangzhou, Zhejiang, China
- +6 more
Sep 7, 2022
Biological Samples From Patients Treated With CAR-T Cells for
Recruiting
- Lymphoma and Acute Lymphoblastic Leukemia
- additional biological samples during CAR-T CELL treatment
-
Montpellier, FranceDépartement d'hématologie clinique
Dec 21, 2021
Haematological Malignancy Trial in Nice (6 sessions of adapted physical activity after stem cell transplant)
Recruiting
- Haematological Malignancy
- 6 sessions of adapted physical activity after stem cell transplant
-
Nice, FranceCHU NICE, hopital ARCHET 1, hématologie
Jun 13, 2022
Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)
Not yet recruiting
- Hematologic Malignancy
- +21 more
- Fludarabine
- +4 more
- (no location specified)
Feb 9, 2023
Hematological Malignancies Treated With Intensive Chemo Trial in Saint-Étienne (Tranexamic acid)
Recruiting
- Hematological Malignancies Treated With Intensive Chemotherapy
- Tranexamic acid
-
Saint-Étienne, FranceCHU de Saint-Etienne
Feb 7, 2022
Hematological Tumors, Recurrence Trial in Shanghai (Peg interferon alfa-2b)
Recruiting
- Hematological Neoplasms
- Recurrence
- Peg interferon alfa-2b
-
Shanghai, Shanghai, ChinaShanghai Jiao Tong University Affilated First People's Hospital
Oct 10, 2021
Immunogenicity of Covid-19 Vaccination for Hematological
Active, not recruiting
- Immunogenicity
- +3 more
-
Varese, Lombardia, ItalyUOC Ematologia, ASST Sette Laghi, Osp. Di Circolo e Fondazione M
Sep 10, 2021
Pseudomonas Aeruginosa, Pneumonia, Hematologic Malignancy Trial in New York (Ceftolozane / Tazobactam Injection)
Suspended
- Pseudomonas Aeruginosa
- +2 more
- Ceftolozane / Tazobactam Injection
-
New York, New YorkWeill Cornell Medicine
Jan 25, 2022
Hematological Malignancies Trial in Guangzhou, Tianjin (Nemtabrutinib)
Recruiting
- Hematological Malignancies
-
Guangzhou, Guangdong, China
- +2 more
Aug 10, 2022
Hematologic Malignancy, Hematologic Tumors, Hematologic Diseases Trial in Nanjing, Suzhou, Tianjin (Flow Cytometry)
Not yet recruiting
- Hematologic Malignancy
- +2 more
- Flow Cytometry
-
Nanjing, Jiangsu, China
- +2 more
Apr 17, 2023
Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Houston (DSP107, Azacitidine, Venetoclax)
Recruiting
- Acute Myeloid Leukemia
- +2 more
- DSP107
- +2 more
-
Houston, TexasThe University of Texas MD Anderson Cancer Center, Department of
Nov 13, 2022
Blood Clots and Bleeding in Hematological Malignancies, HAT
Recruiting
- Acute Leukemia
- +7 more
- Biospecimen Collection
- Electronic Health Record Review
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jun 17, 2022
Tissue Specimens From Solid Tumors or Blood Disorders and Their
Recruiting
- Neoplasms
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Hematological Malignancies Trial in Philadelphia (radiation, drug, genetic)
Recruiting
- Hematological Malignancies
- Total Body Irradiation
- +6 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 4, 2022
Solid Tumor, Hematological Malignancies Trial in Santa Monica (Belinostat, Atazanavir)
Recruiting
- Solid Tumor
- Hematological Malignancies
-
Santa Monica, CaliforniaJohn Wayne Cancer Institute @ Providence Saint John's Health Cen
Jan 31, 2023
Optical Genome Mapping in Hematological Malignancies
Recruiting
- MDS
- +2 more
-
Brest, France
- +3 more
Aug 16, 2021
Hematological Malignancies Trial in Durham (fostamatinib)
Active, not recruiting
- Hematological Malignancies
-
Durham, North CarolinaDuke University of Medicine
Jul 14, 2022
Hematological Malignancies Trial in United Kingdom, United States (Magrolimab, Azacitidine)
Active, not recruiting
- Hematological Malignancies
- Magrolimab
- Azacitidine
-
Duarte, California
- +26 more
Dec 7, 2022
T-cell Lymphoma, T-cell Leukemia Trial in Indianapolis (CD4CAR)
Recruiting
- T-cell Lymphoma
- T-cell Leukemia
- CD4CAR
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Dec 16, 2022
Acute Myeloid Leukemia, MDS Trial in China (TQB2928 Injection + Azacitidine for injection)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- TQB2928 Injection + Azacitidine for injection
-
Beijing, Beijing, China
- +8 more
Aug 22, 2023
Adapted Physical Activity, Hematological Malignancies, Anxiety Trial (Classical APA group:, APA with Exergaming device, APA
Not yet recruiting
- Adapted Physical Activity
- +3 more
- Classical APA group:
- +2 more
- (no location specified)
Jul 25, 2022
Hematological Malignancies Trial in Beijing, Tianjin (TQB3820 tablets)
Recruiting
- Hematological Malignancies
- TQB3820 tablets
-
Beijing, Beijing, China
- +1 more
Sep 18, 2021